The remedē System (ZOLL Medical, Minnetonka, MN; Fig 1), which was approved by the Food and
Drug Administration in October of 2017, is a transvenous device that stimulates the
phrenic nerve for the treatment of central sleep apnea, which is often associated
with heart failure and atrial fibrillation. Given the similarity in implantation procedure
to pacemakers and implantable cardioverter/defibrillators, the remedē System implantation often occurs in the electrophysiology laboratory. Despite
the transvenous nature and close proximity to cardiac structures on radiographic imaging,
the remedē System does not have any cardiac pacing function/antiarrhythmia therapies, and
it is important for an anesthesiologist to be able to recognize and manage such a
device if they were to come across one preoperatively.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Cardiothoracic and Vascular AnesthesiaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Central sleep apnea.Compr Physiol. 2013; 3: 141-163
- Central sleep apnea.Clin Geriatr Med. 2021; 37: 469-481
- Prevalence of sleep-disordered breathing in women: Effects of gender.Am J Respir Crit Care Med. 2001; 163: 608-613
- Sleep-disordered breathing in patients with symptomatic heart failure. A contemporary study of prevalence in and characteristics of 700 patients.Eur J Heart Fail. 2007; 9: 251-257
- Association between atrial fibrillation and central sleep apnea.Sleep. 2005; 28: 1543-1546
- Continuous positive airway pressure for central sleep apnea and heart failure.N Engl J Med. 2005; 353: 2025-2033
- Transvenous neurostimulation for central sleep apnoea: A randomised controlled trial.Lancet. 2016; 388: 974-982
- How to implant a phrenic nerve stimulator for treatment of central sleep apnea?.J Cardiovasc Electrophysiol. 2019; 30: 792-799
- Two implantable devices for cardiac rhythm management.J Cardiothorac Vasc Anesth. 2023; 37: 326-329
ZOLL. remedē System: System Implant and Clinician Use Manual. Available at: https://remede.zoll.com/clinicians/patient-pathway/remede-implant-procedure/. Accessed November 1, 2022.
- Sustained 12 month benefit of phrenic nerve stimulation for central sleep apnea.Am J Cardiol. 2018; 121: 1400-1408
Article info
Publication history
Published online: January 12, 2023
Identification
Copyright
© 2023 Elsevier Inc. All rights reserved.
